CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB MAINTENANCE THERAPY

David Laharie  ¹     Corey A Siegel  ²     Karen Samaan  ³     Deborah Fisher  ³     Nathan Morris  ³     Isabel Redondo  ³     Parambir Singh Dulai  ⁴     Vipul Jairath  ⁵     Javier Gisbert  ⁶     Matsuoka Katsuyoshi  ^7    
1 CHU de Bordeaux Hopital Haut-Leveque Dept. de Gastroenterologie, Pessac cedex, France
² Dartmouth-Hitchcock Medical Center, Lebanon, United States
³ Eli Lilly and Company, Indianapolis, United States
⁴ Northwestern University, Chicago, United States
⁵ Western University, London, Canada
⁶ Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa and CIBEREHD, Madrid, Spain
⁷ Toho University Sakura Medical Center, Sakura, Japan

Topic
IBD

Session
IL-23: Many but different? (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)